Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display

Biomaterials Science(2022)10.1039/d2bm01132hSource: DataRank Database

Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display is a research paper published in Biomaterials Science (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (35)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Jo A. Tucker ORCID,A. Gonzaga Ramírez ORCID,Enya Li ORCID,Vijaykumar S. Meli ORCID,Edward L. Nelson ORCID

Live enrichment

PubMed:36476811 PMC:PMC10775882

National Institute of Biomedical Imaging and Bioengineering

Grant: R01EB027797

National Cancer Institute

Grant: P30CA062203

NIGMS NIH HHS

Grant: R01 GM129325

National Institutes of Health

Grant: 1R01EB027797-01

Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined Immunotherapy

National Institutes of Health

Grant: 5R01GM129325-08

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling

National Institutes of Health

Grant: 3P30CA062203-27S1

Clinical Trial Advancement and Development for Sarcomas

greenLicense: Royal Society of Chemistry Licence to Publish

repositoryhttps://escholarship.org/content/qt1zx0b2px/qt1zx0b2px.pdf

publisherhttp://pubs.rsc.org/en/content/articlepdf/2023/BM/D2BM01132H

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10775882/pdf/nihms-1952932.pdf

https://doi.org/10.1039/d2bm01132h

https://pubmed.ncbi.nlm.nih.gov/36476811

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Dendritic CellsCD8-Positive T-LymphocytesHumansNeoplasmsVaccinesCytokinesToll-Like Receptor 9

Keywords

ImmunologyMedical Biotechnology610BioengineeringCD8-Positive T-LymphocytesVaccine RelatedMedicinal and Biomolecular ChemistryNeoplasms616NanotechnologyHumansCancerVaccinesBiomedical and Clinical SciencesPreventionDendritic CellsGood Health and Well Being5.1 PharmaceuticalsToll-Like Receptor 9CytokinesImmunizationBiochemistry and Cell BiologyInfectionBiomedical engineeringBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health